LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 1401 | 4093 | 3978 | 1.0288 | 1.0380 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1401 | 4458 | 4213 | 1.0581 | 1.0724 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1401 | 4153 | 4545 | 0.9136 | 0.8963 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1401 | 4413 | 3978 | 1.1092 | 1.1425 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1401 | 5062 | 4213 | 1.2014 | 1.2450 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1401 | 4331 | 4545 | 0.9527 | 0.9437 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1401 | 4132 | 3978 | 1.0386 | 1.0509 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1401 | 4576 | 4213 | 1.0861 | 1.1068 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1401 | 4525 | 4545 | 0.9954 | 0.9946 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 1401 | 4308 | 3978 | 1.0828 | 1.1085 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 1401 | 4724 | 4213 | 1.1212 | 1.1494 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 1401 | 4720 | 4545 | 1.0383 | 1.0448 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 1401 | 4049 | 3978 | 1.0177 | 1.0235 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 1401 | 4094 | 4213 | 0.9717 | 0.9642 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 1401 | 4485 | 4545 | 0.9866 | 0.9842 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 1401 | 3369 | 4139 | 0.8140 | 0.7531 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 1401 | 3024 | 4095 | 0.7384 | 0.6440 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 1401 | 3221 | 4272 | 0.7539 | 0.6778 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1401 | 3117 | 4139 | 0.7531 | 0.6680 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1401 | 2966 | 4095 | 0.7242 | 0.6235 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1401 | 3161 | 4272 | 0.7399 | 0.6583 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1401 | 2819 | 4139 | 0.6811 | 0.5641 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1401 | 2905 | 4095 | 0.7093 | 0.6018 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1401 | 2812 | 4272 | 0.6582 | 0.5419 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1401 | 3139 | 4139 | 0.7584 | 0.6755 |